Kemocarb Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Carboplatin

Indications/Uses

Advanced ovarian cancer of epithelial origin. Small cell & non-small cell carcinoma of lung. Squamous cell carcinoma of head & neck. Advanced transitional cell carcinoma of bladder (in combination w/ other agents). Cervix carcinoma.

Dosage/Direction for Use

IV Previously untreated adult w/ normal renal function 400 mg/m² as single short-term infusion over 15-60 min. Renal impairment (CrCl 41-59 mL/min) Starting dose: 250 mg/m², 16-40 mL/min Starting dose: 200 mg/m².

Contraindications

History of severe allergic reactions to cisplatin or other platinum-containing compd. Patients w/ severe bone marrow depression or significant bleeding. Pre-existing severe renal impairment.

MIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01XA02 - carboplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Kemocarb conc for soln for infusion 10 mg/mL

Packing/Price

1's

Kemocarb

carboplatin

Manufacturer:

Fresenius Kabi Oncology